Development and characterization of Spraydried amorphous solid dispersion of phosphodiesterase5 (PDE5) inhibitor: in vivo evaluation of sexual behavior in male rats

Pharmacology, Toxicology and Pharmaceutical Science

1. Erectile Dysfunction 100%
2. Amorphous Solid Dispersion 100%
3. Tadalafil 93%
4. Glycyrrhizin 39%
5. Bioavailability 25%
6. Drug Carrier 20%
7. Sildenafil 18%
8. Dosage Form 13%
9. Pharmaceutics 13%
10. Phosphodiesterase V Inhibitor 11%
11. Cyclic GMP 11%
12. Phosphodiesterase V 11%
13. Diabetes Mellitus 9%
14. Drug Release 9%
15. Pulmonary Hypertension 9%
16. Scanning Electron Microscopy 9%
17. Triterpenoid Saponin 6%
18. Drug Discovery 6%
19. Glycoside 6%
20. Differential Scanning Calorimetry 6%
21. Prevalence 6%
22. Drug Solubility 6%
23. Nitric Oxide 6%
24. Complexation 6%
25. Combination Therapy 6%